Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 17 02 2020
accepted: 05 06 2020
pubmed: 9 7 2020
medline: 30 9 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

To investigate treatment and survival over three decades. Clinical registry data from three major public hospitals analysed using Kaplan-Meier product-limit estimates and multivariate proportional hazard regression to determine disease-specific survival. Five-year survival increased from 75% to 84%. The adjusted hazard ratio (HR, 95% CI) was 0.56 (0.41, 0.77) for 2010-2016 compared with 1984-1989 and was higher for: ages 80+ years; more advanced stages; poorly differentiated tumours; and complex mixed epithelial and mesenchymal tumours and sarcomas. Treatment was by surgery (92%), radiotherapy (33%), chemotherapy (12%) and hormone therapy (10%). Adjusted analyses showed radiotherapy and hormone therapy were less common from 1990 and chemotherapy more common for 2010-2016. Treatment likelihood was lower for ages ≥80 years, mixed epithelial and mesenchymal tumours receiving surgery and chemotherapy, but higher for radiotherapy. Advanced cancers (FIGO stage IV) had less surgery but more non-surgical treatments. Marginal evidence presented of more hormone therapy for high socio-economic areas. Survival was equivalent to national figures for Australia and the United States, but potentially higher than for England and Wales. Cases aged 80+ years had less care and poorer survival. Findings illustrate the complementary roles of hospital and population-based registries in local service evaluation.

Identifiants

pubmed: 32639088
doi: 10.1111/ecc.13281
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e13281

Subventions

Organisme : Cancer Council South Australia: Beat Cancer Project

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

American College of Surgeons. (2016). Facility Oncology Registry Standards (FORDS): Revised for 2016. Chicago, IL: American College of Surgeons.
Arem, H., & Irwin, M. L. (2013). Obesity and endometrial cancer survival: A systematic review. International Journal of Obstetrics (London), 37(5), 634-639. https://doi.org/10.1038/ijo.2012.94
Armitage, P., Berry, G., & Mathews, J. N. S. (1987). Statistical methods in medical research (2nd edn). Oxford, UK: Blackwell Scientific Publications. https://doi.org/10.1002/sim.4780070711
Australian Bureau of Statistics. (2018). Socio-Economic indexes for areas. Canberra: ABS. Retrieved from https://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa
Australian Institute of Health and Welfare (AIHW). (2008). Cancer Australia and Australasian Association of Cancer Registries. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Cancer Series no. 42. Cat. No. CAN 38. Canberra: AIHW.
Australian Institute of Health and Welfare (AIHW). (2017a). Cancer in Australia 2017. Cancer series no. 101. Cat. no. CAN 100. Canberra: AIHW.
Australian Institute of Health and Welfare (AIHW). (2017b). Australian Cancer Incidence and Mortality (ACIM) books. Canberra: AIHW. Retrieved from http://www.aihw.gov.au/acim-books/
Australian Institute of Health and Welfare (AIHW). (2019). Cancer in Australia 2019. Cancer series no. 119. Cat. no. CAN 123. Canberra: AIHW.
Bonett, A., Roder, D., & Esterman, A. (1988). Cancer case-survival rates for South Australia: A comparison with US rates and a preliminary investigation of time trends. Medical Journal of Australia, 148(11), 556-559. https://doi.org/10.5694/j.1326-5377.1988.tb93810.x
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. The New England Journal of Medicine, 348(17), 1625-1638. https://doi.org/10.1056/NEJMoa021423
Cancer Research UK. (2018). Uterine cancer risk. London: Cancer Research UK. Retrieved from https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/risk-factors
Fine, J. P., & Gray, R. J. (1999). A proportional hazards model for subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496-509. https://doi.org/10.1080/01621459.1999.10474144
Fritz, A., C. Percy, A. Jack, K. Shanmugaratnam, L. Sobin, D. M. Parkin, & S. Whelan (eds.) (2000). International classification of diseases for oncology: ICD-0 (3rd edn). Geneva: World Health Organization.
Government of South Australia. (2017). South Australia: Health Care Act 2008 - Part 7. Version: 5.6.2017. Adelaide: South Australian Government.
Noone, A. M., Howlader, N., Krapcho, M., Miller, D., Brest, A., Yu, M., Cronin, K. A. (eds) (2018). SEER cancer statistics review, 1975-2015. Bethesda, MD: National Cancer Institute. Retrieved from https://seer.cancer.gov/csr/1975_2015/
Pecorelli, S. (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynecology & Obstetrics, 105(2), 103-104. https://doi.org/10.1016/j.ijgo.2009.02.012
Roder, D., Karapetis, C. S., Wattchow, D., Moore, J., Singhal, N., Joshi, R., … Price, T. J. (2015). Colorectal cancer treatment and survival: The experience of major public hospitals in South Australia over three decades. Asian Pacific Journal of Cancer Prevention, 16(6), 2431-2440. https://doi.org/10.7314/APJCP.2015.16.6.2431
Roulson, J. A., Benbow, E. W., & Hasleton, P. S. (2005). Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology, 47(6), 551-559. https://doi.org/10.1111/j.1365-2559.2005.02243.x
South Australian Cancer Registry. (1997). Epidemiology of cancer in South Australia. Incidence, mortality and survival 1977 to 1996. Issue 19, Cancer Series. Adelaide: South Australian Department of Health.
South Australian Cancer Registry. (2000). Epidemiology of cancer in South Australia. Incidence, mortality and survival 1977 to 1999. Issue 22, Cancer Series. Adelaide: South Australian Department of Health.
South Australian Cancer Registry. (2007). Cancer in South Australia 2004 with incidence projections to 2007. Adelaide: South Australian Cancer Registry.
StataCorp. (2018). Stata statistical software. Release 16. College Station, TX: StataCorp LP.
Yost, K. J., Cheville, A. L., Al-Hilli, M. M., Mariani, A., Barrette, B. A., McGree, M. E., … Dowdy, S. C. (2014). Lymphedema after surgery for endometrial cancer: Prevalence, risk factors, and quality of life. Obstetrics and Gynecology, 124(201), 307-315. https://doi.org/10.1097/AOG.0000000000000372

Auteurs

David Roder (D)

Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.

Sudarsha Selva-Nayagam (S)

Medical Oncology, Royal Adelaide Hospital Cancer Centre, Adelaide, SA, Australia.

Sellvakumaran Paramasivam (S)

Gynaecological Oncology, Flinders Medical Centre, Adelaide, SA, Australia.

Dorothy Keefe (D)

Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.

Ian Olver (I)

Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.

Caroline Miller (C)

Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
Health Policy Centre, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.

Elizabeth Buckley (E)

Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.

Kate Powell (K)

SA Clinical Cancer Registry, SA Health, Adelaide, SA, Australia.

Kellie Fusco (K)

Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.

Dianne Buranyi-Trevarton (D)

SA Clinical Cancer Registry, SA Health, Adelaide, SA, Australia.

Martin Oehler (M)

Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH